Announce Date | 07/17/2025 |
EPS Normalized Actual | $1.11 (Beat by $0.04) |
EPS GAAP Actual | $1.11 (Beat by $0.04) |
Revenue Actual | $7.604B |
Revenue Surprise | Beat by $7604M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.10153 |
EPS GAAP Estimate | $1.10153 |
Revenue Estimate | $7.207397889B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 0 | INF | 0 | 0 | 0 |
Dec 2025 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.11 | 1.11 | 7.604B | -42.03% | 546.47M |
FQ1 2025 (Mar 2025) | 1.03 | 1.03 | 10.35B | -1.1% | 3438.25M |
FQ4 2024 (Dec 2024) | 1.02 | 1.02 | 6.979B | 3.55% | 11.16M |
FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 2.7B | -159.26% | 2700M |
FQ2 2024 (Jun 2024) | 1.03 | 1.03 | 10.8B | 100% | 10800M |
FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 10.464B | 100% | 10464M |
FQ4 2023 (Dec 2023) | 0 | 0 | 6.731B | 100% | 6731M |
FQ3 2023 (Sep 2023) | 0.91 | 0.91 | 7B | 100% | 7000M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
1.10153
Consensus Revenue Estimates
7.207397889B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.39935 | -- | 1.39092 | 1.40581 | 1 |
FQ3 2027 (Sep 2027) | 1.2798 | -- | 1.27235 | 1.28699 | 1 |
FQ2 2027 (Jun 2027) | 1.2661 | -- | 1.25873 | 1.27322 | 1 |
FQ1 2027 (Mar 2027) | 1.14785 | -- | 1.14094 | 1.15315 | 1 |
FQ4 2026 (Dec 2026) | 1.288 | -- | 1.28024 | 1.29395 | 1 |
FQ3 2026 (Sep 2026) | 1.24628 | -- | 1.23903 | 1.25328 | 1 |
FQ2 2026 (Jun 2026) | 1.20716 | 8.05 | 1.20013 | 1.21394 | 1 |
FQ1 2026 (Mar 2026) | 1.05536 | 2.4 | 1.049 | 1.06023 | 1 |
FQ4 2025 (Dec 2025) | 1.12946 | 9.69 | 1.12266 | 1.13467 | 1 |
FQ3 2025 (Sep 2025) | 1.10153 | 0.14 | 1.09512 | 1.10772 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 10.95B | -- | 10.9B | 10.99B | 5 |
FQ3 2027 (Sep 2027) | 14.91B | -- | 14.84B | 14.98B | 9 |
FQ2 2027 (Jun 2027) | 14.38B | -- | 14.31B | 14.44B | 6 |
FQ1 2027 (Mar 2027) | 9.82B | -- | 9.77B | 9.85B | 5 |
FQ4 2026 (Dec 2026) | 7.61B | -- | 7.58B | 7.64B | 5 |
FQ3 2026 (Sep 2026) | 7.6B | -- | 7.57B | 7.63B | 8 |
FQ2 2026 (Jun 2026) | 7.46B | -1.9 | 7.43B | 7.49B | 5 |
FQ1 2026 (Mar 2026) | 7.13B | -45.13 | 7.1B | 7.16B | 5 |
FQ4 2025 (Dec 2025) | 7.19B | 2.98 | 7.16B | 7.22B | 9 |
FQ3 2025 (Sep 2025) | 7.21B | 62.54 | 7.18B | 7.24B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | 1.11 | 1.11 | 100% |
FQ1 2025 (Mar 2025) | 0 | 1.03 | 1.03 | 100% |
FQ4 2024 (Dec 2024) | 0 | 1.02 | 1.02 | 100% |
FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 100% | |
FQ2 2024 (Jun 2024) | 1.03 | 1.03 | 100% | |
FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0.91 | 0.91 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $7.06B | $7.6B | $546.47M | 7.19% |
FQ1 2025 (Mar 2025) | $6.91B | $10.35B | $3438.25M | 33.22% |
FQ4 2024 (Dec 2024) | $6.97B | $6.98B | $11.16M | 0.16% |
FQ3 2024 (Sep 2024) | $0B | $2.7B | $2700M | 100% |
FQ2 2024 (Jun 2024) | $0B | $10.8B | $10800M | 100% |
FQ1 2024 (Mar 2024) | $0B | $10.46B | $10464M | 100% |
FQ4 2023 (Dec 2023) | $0B | $6.73B | $6731M | 100% |
FQ3 2023 (Sep 2023) | $0B | $7B | $7000M | 100% |